Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-02 Purchase | 2026-06-02 4:25 pm | Ascendis Pharma A/S | ASND | SMITH SCOTT THOMAS EVP & Chief Financial Officer | 100 | $219 | $21,900 | 4,367 (Direct) | View |
| 2026-05-29 Purchase | 2026-06-01 4:11 pm | Ascendis Pharma A/S | ASND | BIENAIME JEAN JACQUES Director | 500 | $223.12 | $111,562 | 900 (Direct) | View |
| 2026-05-29 Purchase | 2026-06-01 4:10 pm | Ascendis Pharma A/S | ASND | SMITH SCOTT THOMAS EVP & Chief Financial Officer | 250 | $223.32 | $55,830 | 4,267 (Direct) | View |
| 2026-05-26 Purchase | 2026-05-27 4:05 pm | Ascendis Pharma A/S | ASND | BIENAIME JEAN JACQUES Director | 400 | $237.8 | $95,121 | 400 (Direct) | View |
| 2026-05-11 Sale | 2026-05-12 4:08 pm | Ascendis Pharma A/S | ASND | JENSEN FLEMMING STEEN See Remarks | 19,460 | $238.49 | $4,641,021 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership(A) | 2026-06-01 4:09 pm | N/A N/A | Ascendis Pharma A/S | ASND | SMITH SCOTT THOMAS EVP & Chief Financial Officer | 0 | $0 | 175,271 (Direct) | View |
Ownership | 2026-04-01 4:10 pm | N/A N/A | Ascendis Pharma A/S | ASND | BIENAIME JEAN JACQUES Director | 0 | $0 | 9,160 (Direct) | View |
Ownership | 2026-03-18 6:14 pm | N/A N/A | Ascendis Pharma A/S | ASND | Fairey William Director | 0 | $0 | 16,651 (Direct) | View |
Ownership | 2026-03-18 6:14 pm | N/A N/A | Ascendis Pharma A/S | ASND | IMANI SIHAM Director | 0 | $0 | 16,851 (Direct) | View |
Ownership | 2026-03-18 6:13 pm | N/A N/A | Ascendis Pharma A/S | ASND | SMITH SCOTT THOMAS EVP & Chief Financial Officer | 0 | $0 | 173,771 (Direct) | View |
Ownership | 2026-03-18 6:12 pm | N/A 2028-12-11 | Ascendis Pharma A/S | ASND | JENSEN MICHAEL WOLFF EVP, Chief Legal Officer | 0 | $0 | 111,254 (Direct) | View |
Ownership | 2026-03-18 6:12 pm | N/A 2031-07-13 | Ascendis Pharma A/S | ASND | Bodenhoff Mads SVP & PAO | 0 | $0 | 46,173 (Direct) | View |
Ownership | 2026-03-18 6:11 pm | N/A N/A | Ascendis Pharma A/S | ASND | PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG EVP & Chief Admin Officer | 0 | $0 | 168,911 (Direct) | View |
Ownership | 2026-03-18 6:11 pm | N/A N/A | Ascendis Pharma A/S | ASND | Morrison Lisa Director | 0 | $0 | 47,024 (Direct) | View |
Ownership | 2026-03-18 6:10 pm | N/A N/A | Ascendis Pharma A/S | ASND | HOLTUG LARS Director | 0 | $0 | 61,583 (Direct) | View |
Ownership | 2026-03-18 6:09 pm | N/A N/A | Ascendis Pharma A/S | ASND | SPROGOE KENNETT See Remarks | 0 | $0 | 151,137 (Direct) | View |
Ownership | 2026-03-18 6:06 pm | N/A N/A | Ascendis Pharma A/S | ASND | Wu Jay Donovan EVP & President US Market | 0 | $0 | 59,032 (Direct) | View |
Ownership | 2026-03-18 6:05 pm | N/A N/A | Ascendis Pharma A/S | ASND | MIKKELSEN JAN MOLLER Director | 0 | $0 | 1,212,618 (Direct) | View |
Ownership | 2026-03-18 6:03 pm | N/A N/A | Ascendis Pharma A/S | ASND | JENSEN FLEMMING STEEN See Remarks | 0 | $0 | 120,714 (Direct) | View |
Ownership | 2026-03-18 6:02 pm | N/A N/A | Ascendis Pharma A/S | ASND | Cha Albert Director | 0 | $0 | 26,619 (Direct) | View |
Ownership | 2026-03-18 6:01 pm | N/A N/A | Ascendis Pharma A/S | ASND | Shu Aimee EVP & Chief Medical Officer | 0 | $0 | 19,281 (Direct) | View |